Sign in

CIK 0001740279

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

IN8BIO, INC.

Sign in to watch
Ticker
INAB
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
825462585
Phone
+1 646-600-6438
Business address
EMPIRE STATE BUILDING, 350 5TH AVENUE, SUITE 5330, NEW YORK, NY, 10118
Former names
Incysus Therapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2023-06-15 Greenwood Luba Director Grant or award · Stock Option (right to buy) +85,000 85,000
2023-06-15 Graff Jeremy R. Director Grant or award · Stock Option (right to buy) +85,000 85,000
2023-06-15 Roemer Alan S. Director Grant or award · Stock Option (right to buy) +85,000 85,000
2023-05-01 Graff Jeremy R. Director Grant or award · Stock Option (right to buy) +27,000 27,000
2023-04-14 Ho William Tai-Wei President and CEO Grant or award · Employee Stock Option (right to buy) +393,950 393,950
2023-04-14 Rochlin Kate Chief Operating Officer Grant or award · Employee Stock Option (right to buy) +200,000 200,000
2023-04-14 McCall Patrick Chief Financial Officer Grant or award · Employee Stock Option (right to buy) +200,000 200,000
2023-04-14 Lamb Lawrence EVP and CSO Grant or award · Employee Stock Option (right to buy) +200,000 200,000
2023-04-14 Ho William Tai-Wei President and CEO Grant or award · Employee Stock Option (right to buy) +393,950 393,950
2023-04-14 Goswami Trishna Chief Medical Officer Grant or award · Employee Stock Option (right to buy) +200,000 200,000
2022-12-12 Kreis Leslie W. Director Purchase +9,214 $2.48 $23K 601,980
2022-12-12 Kreis Leslie W. Director Purchase +57,052 $2.48 $141K 3,727,597
2022-12-12 Kreis Leslie W. Director Purchase +8,735 $2.48 $22K 570,724
2022-12-12 Fletcher Aaron G.L. Director Purchase +9,214 $2.48 $23K 601,980
2022-12-12 Fletcher Aaron G.L. Director Purchase +57,052 $2.48 $141K 3,727,597
2022-12-12 Fletcher Aaron G.L. Director Purchase +8,735 $2.48 $22K 570,724
2022-10-21 McCall Patrick Chief Financial Officer Grant or award · Employee Stock Option (right to buy) +59,796 59,796
2022-10-21 Rochlin Kate Chief Operating Officer Grant or award · Employee Stock Option (right to buy) +60,555 60,555
2022-10-21 Lamb Lawrence EVP and CSO Grant or award · Employee Stock Option (right to buy) +62,826 62,826
2022-10-21 Ho William Tai-Wei President, CEO and CFO Grant or award · Employee Stock Option (right to buy) +83,265 83,265

Page 10 of 16 · 309 trades